4 bedroom house for Sale at Lot 2738 Lilly Pilly Park Way - Riverfield Estate, Clyde VIC 3978. View property photos, floor plans, local school catchments & lots more on Domain.com.au. 2020093795 ...

Christopher Thé previously owned Black Star Pastry. He now has a new café, Hearthe. Christopher is now making rainforest ...

3 bedroom house for Sale at 179 Lilly Pilly Close, Nambucca Heads NSW 2448. View property photos, floor plans, local school catchments & lots more on Domain.com.au. 2019907556 ...

I grew up holidaying in Port Macquarie and have fond childhood memories of camping at the Breakwall Caravan Park and having endless fun at the beach. We loved those trips to Port Macquarie – it […] ...

Pilly Labs, a natural wellness company dedicated to harnessing the power of nature, announces the release of its comprehensive line of single-ingredient supplements designed to enhance overall ...

Company Introduces 100% Natural Gummy Supplements Including Mushroom, Collagen, and Turmeric FormulationsChicago, June 06, 2025 (GLOBE NEWSWIRE) -- Pilly Labs, a natural wellness company dedicated to ...

Lilly Pilly Contrasting foliage. Vegies. Featured Plants CAMELLIA: Camellia cv. GREVILLEA ‘PEACHES AND CREAM’ Grevillea cv. GREVILLEA ‘SANDRA GORDON’ Grevillea cv. ZIGZAG ...

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and the risks. Click for my LLY stock update.

Eli Lilly (NYSE:LLY) recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovarian cancer.

Eli Lilly is counting on Camurus and its long-acting delivery technology to help take its portfolio of obesity and diabetes drugs to the next level with a licensing deal worth up to $870 million.

A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose up to 1.5%.